These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13505224)

  • 1. [Evaluation of results of the treatment of multiple sclerosis with hemolyzed blood].
    KOZIK M; WENDER M
    Pol Tyg Lek (Wars); 1957 Aug; 12(35):1352-6. PubMed ID: 13505224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of diseases of the nervous system with patients hemolyzed blood with special reference to multiple sclerosis; preliminary communication].
    PRUSAK L
    Pol Tyg Lek (Wars); 1954 Nov; 9(46):1471-5. PubMed ID: 13236742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of multiple sclerosis using hemolyzed blood of the patient].
    PRUSAK L
    Neurol Neurochir Psychiatr Pol; 1958; 8(2):173-6. PubMed ID: 13566370
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?].
    Schmidt S; Hohlfeld R
    Nervenarzt; 1995 Apr; 66(4):304-7. PubMed ID: 7783819
    [No Abstract]   [Full Text] [Related]  

  • 5. Caveat regarding immunoglobulin therapy in multiple sclerosis.
    Cross AH; Trotter JL; Hart WM
    Ann Neurol; 1993 Jun; 33(6):660-1. PubMed ID: 8338598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the treatment of disseminated sclerosis with antireticular cytotoxic serum according to A. Bogomoletz].
    CENDROWSKI W
    Pol Tyg Lek (Wars); 1958 Jan; 13(4):134-7. PubMed ID: 13542267
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
    Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: implications for treatment.
    Pittock SJ
    Neurology; 2007 Feb; 68(7):480-1. PubMed ID: 17296911
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D; Weishaupt A; van den Brandt J; Müller N; Beyersdorf N; Ip CW; Toyka KV; Hünig T; Gold R; Kerkau T; Reichardt HM
    Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of newer method of the treatment of disseminated sclerosis].
    WARECKA K
    Pol Tyg Lek (Wars); 1956 Oct; 11(44):1875-9. PubMed ID: 13419655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of treatment of disseminated sclerosis].
    Fog T
    Ugeskr Laeger; 1965 Dec; 127(49):1576-7. PubMed ID: 5868331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis].
    Vasilescu N; Bulandra R; Ionescu M
    Neurol Psihiatr Neurochir; 1968; 13(6):521-31. PubMed ID: 5719427
    [No Abstract]   [Full Text] [Related]  

  • 13. Despair of repair.
    Stangel M; Hartung HP
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):1-4. PubMed ID: 11784815
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effectiveness of blood transfusion in combined treatment of multiple sclerosis].
    Gertsev NF
    Vrach Delo; 1966 Jan; 1():148-9. PubMed ID: 5974045
    [No Abstract]   [Full Text] [Related]  

  • 15. Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
    Longbrake EE; Racke MK
    Expert Rev Neurother; 2009 Mar; 9(3):319-21. PubMed ID: 19271940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of the treatment of multiple sclerosis with sulfurated oil and bibazol].
    GEORGIEV I; IORDANOV B
    Suvr Med (Sofiia); 1957; 8(3):49-53. PubMed ID: 13506912
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of neuropsychiatric conditions associated with multiple sclerosis.
    Ameis SH; Feinstein A
    Expert Rev Neurother; 2006 Oct; 6(10):1555-67. PubMed ID: 17078794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
    Créange A; Farge-Bancel D
    Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cortisone treatment in multiple sclerosis; comparison with other treatment methods].
    OTT B
    Nervenarzt; 1958 Jan; 29(1):33-5. PubMed ID: 13517457
    [No Abstract]   [Full Text] [Related]  

  • 20. New targets for treatment of multiple sclerosis.
    Steinman L
    J Neurol Sci; 2008 Nov; 274(1-2):1-4. PubMed ID: 18768188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.